Atea Pharmaceuticals, Inc. (AVIR)
Nasdaq: AVIR · CIK 0001593899 · United States
Every official Atea Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AVIR filings
Atea Pharmaceuticals, Inc. documents
- Atea Pharmaceuticals, Inc. 10-K 2026AVIR 10-K 2026: annual report for fiscal 2026
- Atea Pharmaceuticals, Inc. 10-K 2025AVIR 10-K 2025: annual report for fiscal 2025
- Atea Pharmaceuticals, Inc. 10-K 2024AVIR 10-K 2024: annual report for fiscal 2024
- Atea Pharmaceuticals, Inc. 10-K 2023AVIR 10-K 2023: annual report for fiscal 2023
- Atea Pharmaceuticals, Inc. 10-K 2022AVIR 10-K 2022: annual report for fiscal 2022
- Atea Pharmaceuticals, Inc. 10-Q 2026AVIR 10-Q 2026: quarterly report for fiscal 2026
- Atea Pharmaceuticals, Inc. 10-Q 2025AVIR 10-Q 2025: quarterly report for fiscal 2025
- Atea Pharmaceuticals, Inc. 10-Q 2024AVIR 10-Q 2024: quarterly report for fiscal 2024
- Atea Pharmaceuticals, Inc. 10-Q 2023AVIR 10-Q 2023: quarterly report for fiscal 2023
- Atea Pharmaceuticals, Inc. 10-Q 2022AVIR 10-Q 2022: quarterly report for fiscal 2022
- Atea Pharmaceuticals, Inc. 8-K 2026AVIR 8-K 2026: current report for fiscal 2026
- Atea Pharmaceuticals, Inc. 8-K 2025AVIR 8-K 2025: current report for fiscal 2025
- Atea Pharmaceuticals, Inc. 8-K 2024AVIR 8-K 2024: current report for fiscal 2024
- Atea Pharmaceuticals, Inc. 8-K 2023AVIR 8-K 2023: current report for fiscal 2023
- Atea Pharmaceuticals, Inc. 8-K 2022AVIR 8-K 2022: current report for fiscal 2022
- Atea Pharmaceuticals, Inc. DEF 14A 2026AVIR DEF 14A 2026: proxy statement for fiscal 2026
- Atea Pharmaceuticals, Inc. DEF 14A 2025AVIR DEF 14A 2025: proxy statement for fiscal 2025
- Atea Pharmaceuticals, Inc. DEF 14A 2024AVIR DEF 14A 2024: proxy statement for fiscal 2024
- Atea Pharmaceuticals, Inc. DEF 14A 2023AVIR DEF 14A 2023: proxy statement for fiscal 2023
- Atea Pharmaceuticals, Inc. DEF 14A 2022AVIR DEF 14A 2022: proxy statement for fiscal 2022
- Atea Pharmaceuticals, Inc. Form 4 2026AVIR Form 4 2026: insider trading filing for fiscal 2026
- Atea Pharmaceuticals, Inc. Form 4 2025AVIR Form 4 2025: insider trading filing for fiscal 2025
- Atea Pharmaceuticals, Inc. Form 4 2024AVIR Form 4 2024: insider trading filing for fiscal 2024
- Atea Pharmaceuticals, Inc. Form 4 2023AVIR Form 4 2023: insider trading filing for fiscal 2023
- Atea Pharmaceuticals, Inc. Form 4 2022AVIR Form 4 2022: insider trading filing for fiscal 2022
- Atea Pharmaceuticals, Inc. S-1 2026AVIR S-1 2026: registration statement for fiscal 2026
- Atea Pharmaceuticals, Inc. S-1 2025AVIR S-1 2025: registration statement for fiscal 2025
- Atea Pharmaceuticals, Inc. S-1 2024AVIR S-1 2024: registration statement for fiscal 2024
- Atea Pharmaceuticals, Inc. S-1 2023AVIR S-1 2023: registration statement for fiscal 2023
- Atea Pharmaceuticals, Inc. S-1 2022AVIR S-1 2022: registration statement for fiscal 2022
- Atea Pharmaceuticals, Inc. 13F 2026AVIR 13F 2026: institutional holdings for fiscal 2026
- Atea Pharmaceuticals, Inc. 13F 2025AVIR 13F 2025: institutional holdings for fiscal 2025
- Atea Pharmaceuticals, Inc. 13F 2024AVIR 13F 2024: institutional holdings for fiscal 2024
- Atea Pharmaceuticals, Inc. 13F 2023AVIR 13F 2023: institutional holdings for fiscal 2023
- Atea Pharmaceuticals, Inc. 13F 2022AVIR 13F 2022: institutional holdings for fiscal 2022
More companies